The Role of Ubiquitination in Drosophila Innate Immunity

Infection of Drosophila by Gram-negative bacteria triggers a signal transduction pathway (the IMD pathway) culminating in the expression of genes encoding antimicrobial peptides. A key component in this pathway is a Drosophila IκB kinase (DmIKK) complex, which stimulates the cleavage and activation...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 280; no. 40; pp. 34048 - 34055
Main Authors Zhou, Rui, Silverman, Neal, Hong, Mei, Liao, Dorothy S., Chung, Yvonne, Chen, Zhijian J., Maniatis, Tom
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 07.10.2005
American Society for Biochemistry and Molecular Biology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Infection of Drosophila by Gram-negative bacteria triggers a signal transduction pathway (the IMD pathway) culminating in the expression of genes encoding antimicrobial peptides. A key component in this pathway is a Drosophila IκB kinase (DmIKK) complex, which stimulates the cleavage and activation of the NF-κB transcription factor Relish. Activation of the DmIKK complex requires the MAP3K dTAK1, but the mechanism of dTAK1 activation is not understood. In human cells, the activation of TAK1 and IKK requires the human ubiquitin-conjugating enzymes Ubc13 and UEV1a. Here we demonstrate that the Drosophila homologs of Ubc13 and UEV1a are similarly required for the activation of dTAK1 and the DmIKK complex. Surprisingly, we find that the Drosophila caspase DREDD and its partner dFADD are required for the activation of DmIKK and JNK, in addition to their role in Relish cleavage. These studies reveal an evolutionarily conserved role of ubiquitination in IKK activation, and provide new insights into the hierarchy of signaling components in the Drosophila antibacterial immunity pathway.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M506655200